Copyright 2009 Medical News Today Latest Diabetes News From Medical News Today. http://www.medicalnewstoday.com/sections/diabetes/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Sat, 04 Jul 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/156428.php http://www.medicalnewstoday.com/articles/156428.php Research led by the German Institute of Human Nutrition (DIfE) has identified a new gene associated with diabetes, together with a mechanism that makes obese mice less susceptible to diabetes. A genomic fragment that occurs naturally in some mouse strains diminishes the activity of the risk gene Zfp69. The researchers also found that the corresponding human gene (ZNF642) is especially active in overweight individuals with diabetes. Diabetes Sat, 04 Jul 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/156431.php http://www.medicalnewstoday.com/articles/156431.php Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that their marketing authorization application for ONGLYZA™ (saxagliptin) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of type 2 diabetes in adults as add-on therapy with metformin, a thiazolidinedione or a sulphonylurea. Diabetes Sat, 04 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156350.php http://www.medicalnewstoday.com/articles/156350.php The Hypertension and Vascular Research Center at Wake Forest University School of Medicine has received renewal of a multi-million dollar grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to continue the development of new approaches to treat hypertension and vascular disease. The program is in its 16th year of existence at the School of Medicine. The $6. Hypertension Sat, 04 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156402.php http://www.medicalnewstoday.com/articles/156402.php Researchers at the University of Oklahoma Health Sciences Center have found a way to use a natural compound to stop one of the leading causes of blindness in the United States. The research appears online this month in the journal Diabetes, a publication of the American Diabetes Association. Eye Health / Blindness Fri, 03 Jul 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/156086.php http://www.medicalnewstoday.com/articles/156086.php Diabetics undergoing total joint replacement often are at a higher risk of experiencing complications after surgery due to various pre-existing health conditions. According to a new study published in the July 2009 issue of The Journal of Bone and Joint Surgery (JBJS), those complications are less likely to occur when a diabetic patient has glucose levels under control. Diabetes Fri, 03 Jul 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/156233.php http://www.medicalnewstoday.com/articles/156233.php A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to researchers at The University of Texas Medical School at Houston. The results of the Phase II trial are published in Diabetes Care, a journal of the American Diabetes Association. Diabetes Fri, 03 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156214.php http://www.medicalnewstoday.com/articles/156214.php Diets high in protein and cholesterol are associated with a higher risk of hospitalization or death due to cirrhosis or liver cancer, while diets high in carbohydrates are associated with a lower risk. These findings are in the July issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience. Liver Disease / Hepatitis Fri, 03 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156217.php http://www.medicalnewstoday.com/articles/156217.php University of Minnesota Medical School researcher Michael Mauer, M.D., has found a treatment that significantly slows the progression of eye injury in people with type 1 diabetes, a common complication caused by this disease. By administering an antihypertensive, medication commonly prescribed to treat high blood pressure, Mauer and colleagues were able to slow progression of diabetic eye damage in more than 65 percent of participants involved in the study. Eye Health / Blindness Thu, 02 Jul 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/156175.php http://www.medicalnewstoday.com/articles/156175.php Johnson & Johnson has announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin® (trastuzumab) , is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists selected Dr. Ullrich, who on September 8 will receive a $100,000 prize during a ceremony in Beerse, Belgium. Cancer / Oncology Thu, 02 Jul 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/156093.php http://www.medicalnewstoday.com/articles/156093.php A new study of obese adolescents has shown that laparoscopic gastric banding surgery -- the "Lap-Band" procedure -- not only helps them achieve significant weight loss but can also improve and even reverse metabolic syndrome, reducing their risk for cardiovascular disease and diabetes. Obesity / Weight Loss / Fitness Thu, 02 Jul 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/156104.php http://www.medicalnewstoday.com/articles/156104.php Major scientific contributors within the bariatric and psychiatric industries publicized the results of a recent study demonstrating that LAP-BAND(R) patients who regularly attend support groups experience considerably higher rates of post-surgical weight loss. Authors Dr. Kathryn A. Kaiser, Dr. Susan Franks and Dr. Adam Smith discussed their findings at the 26th Annual American Society for Metabolic & Bariatric Surgery (ASMBS) Meeting. Obesity / Weight Loss / Fitness Wed, 01 Jul 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/156010.php http://www.medicalnewstoday.com/articles/156010.php Researchers have found evidence that chronic disease in either a mother or father can create unfavourable conditions in the womb that are associated with the development of polycystic ovarian syndrome (PCOS) in daughters. In another study, researchers found that brothers of women with PCOS and insulin resistance are themselves at greater risk of developing insulin resistance or diabetes, suggesting that factors associated with the condition can be passed down to sons as well as daughters. Women's Health / Gynecology Wed, 01 Jul 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/156015.php http://www.medicalnewstoday.com/articles/156015.php Experts are predicting record-breaking temperatures this week, so it's important to take precautions to ensure that your diabetes remains well-controlled in this extreme weather. Long periods of inactivity in the sun can affect diabetes control, making blood glucose levels higher than usual. On the flipside, insulin will be absorbed more quickly from the injection site in hot weather and this increases the risk of hypos. Diabetes Wed, 01 Jul 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/156017.php http://www.medicalnewstoday.com/articles/156017.php The latest National Diabetes Audit has revealed that 60 per cent of people with diabetes in England do not receive all of their vital annual health checks including blood glucose, blood pressure and eye tests. Diabetes Wed, 01 Jul 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/156009.php http://www.medicalnewstoday.com/articles/156009.php Women with cystic fibrosis can have fertility treatment to help them have babies without any long-term adverse effects on either themselves or their children, according to new research presented at the 25th annual meeting of the European Society of Human Reproduction and Embryology in Amsterdam. Until relatively recently, cystic fibrosis (CF) was a death sentence and most people with the disease died by the time they reached their teenage years. Cystic Fibrosis Wed, 01 Jul 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/155948.php http://www.medicalnewstoday.com/articles/155948.php PPD, Inc. (NASDAQ: PPDI) today announced that Takeda Pharmaceutical Company Limited issued a news release reporting that Takeda Global Research & Development Center, Inc., its wholly-owned U.S. subsidiary, has received a complete response letter from the U.S. Food and Drug Administration (FDA) regarding its new drug application (NDA) for alogliptin. Diabetes Wed, 01 Jul 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/155920.php http://www.medicalnewstoday.com/articles/155920.php Roche, the maker of ACCU-CHEK blood glucose monitoring systems and insulin pumps, announced today the latest component of its Behavior Change through Patient Engagement (sm) program. Creative Coaching is an advanced educational program that fights the growing epidemic of diabetes by improving dialogue between diabetes educators and their patients. Diabetes Wed, 01 Jul 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/155907.php http://www.medicalnewstoday.com/articles/155907.php UK experts are calling for greater consideration of gastric banding as an option for obese people with type 2 diabetes who need to lose weight. Dr Jonathan Pinkney, diabetologist, and Mr Paul Super, obesity surgeon, initiated this call to action following the recent European label change confirming that weight loss with Allergan's LAP-BAND [TM] AP System can lead to improvement or remission of type 2 diabetes. Obesity / Weight Loss / Fitness Tue, 30 Jun 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/155854.php http://www.medicalnewstoday.com/articles/155854.php Diabetes UK has so far encouraged more than 10,000 people in the UK to measure their waists and find out if they are at risk of developing Type 2 diabetes with its national Measure Up Roadshow which kicked off on June 3. The Measure Up Roadshow is touring the country until December in a bid to help people find out more about Type 2 diabetes and its risk factors. Diabetes Tue, 30 Jun 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/155840.php http://www.medicalnewstoday.com/articles/155840.php Researchers from North Carolina State University and Mayo Clinic have developed a computer model that medical doctors can use to determine the best time to begin using statin therapy in diabetes patients to help prevent heart disease and stroke. "The research is significant because patients with diabetes are at high risk for cardiovascular disease and statins are the single most commonly used treatment for patients at risk of heart disease and/or stroke," says Dr. Diabetes Tue, 30 Jun 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/155759.php http://www.medicalnewstoday.com/articles/155759.php The European Medicines Agency (EMEA) is looking into four recently published registry studies investigating a possible relationship between insulin analogues, in particular insulin glargine, and the risk of cancer. The studies were published on the Diabetologia website on 26 June 2009. Diabetes Tue, 30 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/155744.php http://www.medicalnewstoday.com/articles/155744.php Takeda Pharmaceutical Company Limited ("Takeda") announced that Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary received on June 26 (U.S. time) a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the Company's New Drug Application (NDA) for alogliptin, a selective dipeptidyl peptidase IV (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise. Diabetes Tue, 30 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/155746.php http://www.medicalnewstoday.com/articles/155746.php On June 26, 2009 several articles published online in Diabetologia by the European Association for the Study of Diabetes investigated the possible relationship between use of insulin glargine (Lantus, sanofi-aventis) and the development of certain malignancies. The authors themselves, and the accompanying editorial, cautioned against over-interpretation of their limited data and analyses, which precluded them from drawing any firm conclusions. Cancer / Oncology Tue, 30 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/155712.php http://www.medicalnewstoday.com/articles/155712.php The International Diabetes Federation (IDF) called for urgent assessment and responses from regulatory authorities into a possible link between the use of insulin glargine (an insulin analogue) and increased risk of cancer based on findings published on 26 June, 2009 in Diabetelogia, the journal of the European Association for the Study of Diabetes (EASD). Diabetes Mon, 29 Jun 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/155697.php http://www.medicalnewstoday.com/articles/155697.php Diabetes UK is asking you to donate your unwanted or broken jewellery and accessories to our jewellery appeal. We will then convert your kind donations into crucial funds to support diabetes research projects. If you have an odd cufflink or earring, a watch that doesn't tick, a damaged necklace or a ring that doesn't fit, please send it to the address below. Diabetes